Abbott: Advances in Diagnostics of Infectious Diseases
Friday, May 15, 2026 ┃14:30-15:30 ┃Seminar room III
Infectious Diseases 2026: From Lab Results to Clinical Decisions
Assoc. Prof. Ieva Tolmane, MD, PhD, MBA, Riga East University Hospital, University of Latvia, GASTRO Center.
Method verification process in Latvian National microbiology reference laboratory
Lubova Rohlina, MD, Department of Immunochemistry, Virology and Parasitology of Infectious Diseases, National Microbiology Reference Laboratory Riga East Clinical University Hospital.
Importance of State-of-the-Art Infectious Disease Diagnostics
Gordon Avery, BSc MSc CSci FIBMS Associate Scientific Director, Core Diagnostics, Medical Affairs EMEA Abbott Laboratories.
Roche: The Next Frontier in Clinical Diagnostics: Mass Spectrometry and Dynamic Biomarkers
Saturday, May 16, 2026 ┃10:30-11:30 ┃Seminar room III
From Guidelines to Practice: Enhancing Antimicrobial Stewardship with Procalcitonin.
Dr. Nuria Arroyo de Prada, Senior Global Clinical Marketing Manager Infectiology, Thermo Fisher Scientific
The Evolving Role of Mass Spectrometry in Diagnostics
Lydia Keckeis, Global Medical Affairs Lead - Mass Spec TDM, Roche
Dr. Dusanka Kasapic, Global Medical Affairs Lead - Mass Spec Steroids & Vitamins, Roche